The SAPH group is a non-profit, national group whose executive committee members receive no salary. It is registered and operates under the STS. Its central office is located at STS offices in Riyadh, Kingdom of Saudi Arabia.
The Saudi Advisory Group for Pulmonary Hypertension (SAPH) is a medical and research body that is considered as a part of the Saudi Thoracic Society (STS) and is devoted to increase the awareness and knowledge of pulmonary vascular diseases (PVD), and to facilitate advances in the treatment of affected people within the Kingdom of Saudi Arabia.
The objectives of SAPH group are following:
- To investigate the local incidence, prevalence, and pathobiology of PVD in Saudi Arabia
- To identify local characteristics of the illness including its morbidity and mortality
- To develop national guidelines for the diagnosis and treatment of PVD
- To provide expertise that will address issues related to the education and training of healthcare professionals in the field of PVD
- To focus on improving the treatment of PVD, by promoting basic and clinical research
- To promote public awareness through different means including print and electronic media, and public seminars
